J&J gives pi­o­neer­ing stem cell biotech its first Big Phar­ma deal, part­ner­ing on iP­SC CAR-T and CAR-NK

Late last sum­mer, one of the ear­li­est stem cell ther­a­py com­pa­nies got two gov­ern­ment de­ci­sions in the span of three weeks: The USP­TO grant­ed them …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA